Cytyc Corporation Appoints Brad Thomas to Lead Human Resources and Organizational Development
Posted on: Wednesday, 18 April 2007, 18:00 CDT
Cytyc Corporation (Nasdaq: CYTC), a leading provider of surgical and diagnostic products targeting women's health and cancer diagnostics, today announced the appointment of Brad Thomas as senior vice president of Human Resources and Organizational Development. In this role, Mr. Thomas will lead the development and implementation of integrated HR programs designed to position the organization for continued growth.
"We are fortunate that the ongoing growth and diversification of our business is creating ever expanding roles and exciting career opportunities. To sustain our success and reward the hard work of our employees, it is critical for us to invest in key individual and organizational development initiatives," said Patrick J. Sullivan, Cytyc's chairman, president, and chief executive officer.
"We are delighted that Brad has accepted this exciting opportunity. His more than 20 years' experience within high performing organizations, and his track record of successfully aligning HR initiatives with business strategy make him a great fit for our Cytyc leadership team."
Mr. Thomas has a broad background of global HR leadership experience at Citigroup, Pepsi, and GE where he has implemented custom programs to improve staffing, performance management, leadership succession, executive development, training, and executive and sales compensation. He is a graduate of the GE Human Resource Leadership Program, holds a BS in Business Administration from Villanova University, as well as, an MBA from Virginia Polytechnic Institute. Mr. Thomas also served as a Captain in the United States Marine Corps.
Cytyc Corporation is a diversified diagnostic and medical device company that designs, develops, manufactures, and markets innovative and clinically effective diagnostic and surgical products. Cytyc's products cover a range of cancer and women's health applications, including cervical cancer screening, preterm birth screening, treatment of excessive menstrual bleeding, radiation treatment of early-stage breast cancer, and radiation treatment of patients with malignant brain tumors.
Cytyc is traded on The NASDAQ Global Select Market under the symbol CYTC. Cytyc is a registered trademark of Cytyc Corporation.
Source: Business Wire
Related Articles
- PC Mall, Inc. Welcomes Joseph Hayek, Executive Vice President, Corporate Development and Investor Relations
- Exeter Engages Michael McPhie As Executive Vice President, Corporate Development and Environment and Appoints Louis Montpellier As a Director
- Tioga Energy Appoints Preston Roper Executive Vice President, Corporate Development and Operations
- Atlas Mining Company Appoints John S. Gaensbauer As Its Executive Vice President, Corporate Development and Strategy and Barbara Suveg As Its Chief Financial Officer
- Third Wave to Collaborate With LabCorp on Development of Companion Diagnostic to Personalize Treatment of Heart Failure
- NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma Cancers
- JetBlue Names Jim Hnat Executive Vice President, Corporate Affairs, and Realigns Leadership Reporting Structure
- Nanogen Wins CDC Contract to Develop Avian Flu Diagnostic
- Focus Diagnostics Signs Agreement With Stratagene Corporation to Develop Real-Time PCR In Vitro Diagnostic Products
- Diagnostic Products Corporation Releases NT-proBNP Assay Outside the US
 |
 |
User Comments (0)
RSS Feeds